These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12549942)

  • 21. Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
    Kahles H; Ertl G; Riegger G; Liebau G; Kochsiek K
    Z Kardiol; 1985; 74 Suppl 2():24-6. PubMed ID: 4002799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of captopril on serum digoxin levels in patients with severe congestive heart failure.
    Kirimli O; Kalkan S; Guneri S; Tuncok Y; Akdeniz B; Ozdamar M; Guven H
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):311-4. PubMed ID: 11471775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans.
    Gurley BJ; Swain A; Barone GW; Williams DK; Breen P; Yates CR; Stuart LB; Hubbard MA; Tong Y; Cheboyina S
    Drug Metab Dispos; 2007 Feb; 35(2):240-5. PubMed ID: 17079360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin?
    Cohen E; Almog S; Staruvin D; Garty M
    Isr Med Assoc J; 2002 Oct; 4(10):772-5. PubMed ID: 12389338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Digoxin: continuous or discontinuous treatment?].
    Gnocchi CA; Mazzocchi O; Yaryour C; Khoury MC; Noel ME; Torn A; Risso JA
    Medicina (B Aires); 1998; 58(3):271-6. PubMed ID: 9713095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of the direct factor Xa inhibitor edoxaban and digoxin administered alone and in combination.
    Mendell J; Noveck RJ; Shi M
    J Cardiovasc Pharmacol; 2012 Oct; 60(4):335-41. PubMed ID: 23064240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Digitalis intoxication secondary to treatment with clarithromycin].
    Bonilla Porras M; Lucena Campillo MA; Delgado Silveira E; Ramallal Jiménez Del Llano MC; García Díaz B
    Farm Hosp; 2005; 29(3):209-13. PubMed ID: 16013947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of exenatide on the steady-state pharmacokinetics of digoxin.
    Kothare PA; Soon DK; Linnebjerg H; Park S; Chan C; Yeo A; Lim M; Mace KF; Wise SD
    J Clin Pharmacol; 2005 Sep; 45(9):1032-7. PubMed ID: 16100297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of itraconazole on digoxin clearance in patients with congestive heart failure].
    Wakasugi H; Ishizuka R; Koreeda N; Yano I; Futami T; Nohara R; Sasayama S; Inui K
    Yakugaku Zasshi; 2000 Sep; 120(9):807-11. PubMed ID: 11019654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients.
    Yasui N; Otani K; Kaneko S; Shimoyama R; Ohkubo T; Sugawara K
    Int Clin Psychopharmacol; 1997 Jul; 12(4):225-9. PubMed ID: 9347384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omeprazole does not modulate pharmacokinetic of digoxin in patients with heart failure.
    Souza FC; Baptista TM; Marques EB; Barros RB; Scaramello CB
    Int J Cardiol; 2015 Jan; 179():343-4. PubMed ID: 25464482
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serum levels and kinetics of digoxin in patients with hyperthyroidism (author's transl)].
    Gaita F; Bocchiardo M; Brossa C; Molinatti GM; Rosettani E; Brusca A
    G Ital Cardiol; 1980; 10(7):836-42. PubMed ID: 7461331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring.
    Englund G; Hallberg P; Artursson P; Michaëlsson K; Melhus H
    BMC Med; 2004 Apr; 2():8. PubMed ID: 15061868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies.
    Eberl S; Renner B; Neubert A; Reisig M; Bachmakov I; König J; Dörje F; Mürdter TE; Ackermann A; Dormann H; Gassmann KG; Hahn EG; Zierhut S; Brune K; Fromm MF
    Clin Pharmacokinet; 2007; 46(12):1039-49. PubMed ID: 18027988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clarithromycin-induced digoxin toxicity: a case report and a review of the literature.
    Xu H; Rashkow A
    Conn Med; 2001 Sep; 65(9):527-9. PubMed ID: 11678058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal assessment of a P-glycoprotein-mediated drug interaction of valspodar on digoxin.
    Kovarik JM; Rigaudy L; Guerret M; Gerbeau C; Rost KL
    Clin Pharmacol Ther; 1999 Oct; 66(4):391-400. PubMed ID: 10546923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cimetidine on steady-state serum digoxin concentrations.
    Fraley DS; Britton HL; Schwinghammer TL; Kalla R
    Clin Pharm; 1983; 2(2):163-5. PubMed ID: 6883945
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.
    Adams KF; Patterson JH; Gattis WA; O'Connor CM; Lee CR; Schwartz TA; Gheorghiade M
    J Am Coll Cardiol; 2005 Aug; 46(3):497-504. PubMed ID: 16053964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No effect of imidafenacin, a novel antimuscarinic drug, on digoxin pharmacokinetics in healthy subjects.
    Nakade S; Ohno T; Nakayama K; Kitagawa J; Hashimoto Y; Ohnishi A; Miyata Y
    Drug Metab Pharmacokinet; 2008; 23(2):95-100. PubMed ID: 18445988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of telaprevir on the pharmacokinetics of midazolam and digoxin.
    Garg V; Chandorkar G; Farmer HF; Smith F; Alves K; van Heeswijk RP
    J Clin Pharmacol; 2012 Oct; 52(10):1566-73. PubMed ID: 22162542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.